Results of papers that reported dysregulation of DSCAM-AS1 in clinical specimens (ANCTs, adjacent non-cancerous tissues; OS, Overall survival; DFS, Disease-free survival; TNM, tumor−node−metastasis; ER, Estrogen Receptor; TR, Tamoxifen−resistant; WT, wild type; TNBC, triple negative breast cancer; RFS, Relapse Free Survival). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.